FDA Accused of Laxity Over Posting of Clinical Trial Results

North America
Written By Justin Mendoza
Read in Bloomberg Law
Read in Bloomberg Law
Justin Mendoza
Previous

Eli Lilly & Co. Price Drop
Next

FDA is petitioned to boost enforcement of trial sponsors that fail to register studies or report results